Galectin Therapeutics Email Format
Pharmaceutical ManufacturingGeorgia, United States11-50 Employees
Galectin Therapeutics is a pharmaceutical developer focused on therapies that target galectin proteins, with an emphasis on fibrotic disease and cancer. The company pursues candidate compounds based on carbohydrate technology that bind and inhibit galectins, aiming to intervene in disease pathways where these proteins play a key role, particularly in liver fibrosis, tumor vaccine enhancement, and colorectal cancer. Its approach centers on developing clinically meaningful options for conditions with serious health risks and limited existing treatments, and it seeks partnerships as programs advance. Based in Norcross, Georgia, the firm operates in the pharmaceutical manufacturing industry and emphasizes a development pathway intended to accelerate clinical enhancement and potential commercialization. Recent activity includes leadership appointments and participation in industry conferences, reflecting ongoing efforts to advance its galectin-targeted programs.
1-888-653-2347 
support@leadiq.com 
